Have other regulators (EMA, MHRA, Health Canada) issued recalls or alerts for gelatide?

Checked on December 1, 2025
Disclaimer: Factually can make mistakes. Please verify important information or breaking news. Learn more.

Executive summary

Available search results do not show any recalls or safety alerts specifically mentioning a product named "gelatide" by the EMA, MHRA or Health Canada; the public databases and guidance pages from those agencies discuss recall processes and list recent recalls, but none of the indexed pages reference "gelatide" (available sources do not mention gelatide) [1][2][3].

1. What the regulators publish and where to look

Europe’s EMA maintains a quality-defect and recall coordination page for centrally authorised medicines and describes how reports of product quality defects are handled centrally [3]. The UK’s MHRA and Canada’s Health Canada also publish advisories, warnings and recall lists on their official portals; Health Canada’s central pages list safety alerts, public health advisories and recalls for drugs and health products [2]. If you’re searching for a specific product name like “gelatide,” those agency databases are the primary places to check [2][3].

2. No evidence in these indexed pages of a gelatide recall

The subset of government pages and recall indexes included in the search results — Health Canada’s advisories and recall portal and the EMA’s quality-defects page — do not include any mention of a product called “gelatide.” The Health Canada recall search page lists recent recalls but the snippets provided do not show gelatide among them [1][2][3]. Therefore, within the available reporting, regulators have not issued a documented recall or alert for gelatide.

3. How regulators communicate recalls — what a true alert would look like

When regulators do publicize recalls or safety alerts they provide product identifiers, affected lots, reason for the recall, and recommended actions; Health Canada’s advisories and recall pages present safety alerts, type I drug recalls and lists of affected lots [2][4]. The EMA’s quality-defect page explains the coordination role for centrally authorised medicines and would be the place to find formal assessments related to product quality defects [3]. Absence of gelatide in those publications means there is no centrally recorded quality-defect notice in the indexed material.

4. Possible reasons you might not find a mention (and limitations of these sources)

Not every recall appears in the limited set of indexed pages returned here. Some possibilities are that a recall could be local (not centrally authorised, notified only at national level), recent and not yet indexed, or communicated by a manufacturer rather than the regulator’s central page. The search results include general recall guidance and portals but do not represent a live, exhaustive scrape of every announcement across all national or company channels [1][2][3]. Available sources do not mention whether a manufacturer communication or a private-market advisory exists for gelatide.

5. Related examples and why they matter for verification

Recent recall examples in the search results illustrate typical triggers regulators publish: Health Canada recently flagged issues such as ibuprofen capsules with cloudy/ crystallized content in the gelatin shell and lists many product recalls on its portal — demonstrating the type of entry you would expect if gelatide were recalled [5][1]. EMA materials similarly show how quality defects are handled for central authorisations [3]. Use these examples as templates when checking whether a product-level notice is present.

6. Practical next steps to confirm or disprove a gelatide recall

Check the live recall/search portals directly: Health Canada’s “Find recalls, advisories and safety alerts” site and the EMA’s quality-defect and recall pages are primary sources [1][3]. If the product is marketed in the UK, review the MHRA site (not in these snippets but comparable to Health Canada/EMA pages). Also search company press releases and distributor communications; if a manufacturer-initiated recall exists it may appear first in corporate channels before regulator index updates. The search results provided do not include those company notices (available sources do not mention manufacturer statements about gelatide).

Limitations and caveats: this analysis relies only on the supplied search results and their snippets; the absence of gelatide in these pages does not prove there is no recall anywhere, only that the provided sources do not cite one [1][2][3].

Want to dive deeper?
Has the EMA issued a recall or safety alert for gelatide?
Has the UK's MHRA published any warnings or recalls about gelatide?
Has Health Canada announced recalls, advisories, or safety reviews for gelatide?
Are there differences in regulatory actions on gelatide between FDA, EMA, MHRA, and Health Canada?
Where can I find official recall notices or safety communications on gelatide from major regulators?